Open AccessA close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system
Author(s) -
Rezabakhsh Aysa,
SadatEbrahimi SeyyedReza,
Ala Alireza,
Nabavi Seyed Mohammad,
Banach Maciej,
Ghaffari Samad
Publication year - 2022
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.17122
Subject(s) - covid-19 , pandemic , intensive care medicine , medicine , disease , stage (stratigraphy) , pathology , infectious disease (medical specialty) , biology , paleontology , outbreak
Based on the recent reports, cardiovascular events encompass a large portion of the mortality caused by the COVID‐19 pandemic, which drawn cardiologists into the management of the admitted ill patients. Given that common laboratory values may provide key insights into the illness caused by the life‐threatening SARS‐CoV‐2 virus, it would be more helpful for screening, clinical management and on‐time therapeutic strategies. Commensurate with these issues, this review article aimed to discuss the dynamic changes of the common laboratory parameters during COVID‐19 and their association with cardiovascular diseases. Besides, the values that changed in the early stage of the disease were considered and monitored during the recovery process. The time required for returning biomarkers to basal levels was also discussed. Finally, of particular interest, we tended to abridge the latest updates regarding the cardiovascular biomarkers as prognostic and diagnostic criteria to determine the severity of COVID‐19.